Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Uterine Cervical Neoplasms 12 Nasopharyngeal Carcinoma 8 Head and Neck Neoplasms 6 Carcinoma, Non-Small-Cell Lung 6 Squamous Cell Carcinoma of Head and Neck 5 Esophageal Neoplasms 5 Recurrence 4 Nasopharyngeal Neoplasms 4 Lung Neoplasms 4 Carcinoma, Hepatocellular 4 Urinary Bladder Neoplasms 3 Stomach Neoplasms 3 Ovarian Neoplasms 3 Osteosarcoma 3 Neuroblastoma 3 Esophageal Squamous Cell Carcinoma 3 Carcinoma, Squamous Cell 3 Small Cell Lung Carcinoma 2 Peritoneal Neoplasms 2 Neoplasms 2 Hyperthermia 2 Fallopian Tube Neoplasms 2 Cholangiocarcinoma 2 Central Nervous System Neoplasms 2 Breast Neoplasms 2 Vulvar Neoplasms 1 Vomiting 1 Virus Diseases 1 Tumor Virus Infections 1 Tongue Neoplasms 1

Interventions

trifluridine tipiracil drug combination 1 tipiracil 1 Trifluridine 1 TP protocol 1 Pemetrexed 1 Paclitaxel 1 PE regimen 1 Cisplatin 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Solid Tumor Cancer × Cisplatin × Clear all

NCT06649448 2024-10-18

EF-001

Shandong Cancer Hospital and Institute

Phase NA Not yet recruiting

Other solid neoplasm

Solid Tumor Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡